Ethic Inc. Has $4.33 Million Stock Position in Agilent Technologies, Inc. (NYSE:A)

Ethic Inc. trimmed its holdings in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 8.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 32,209 shares of the medical research company's stock after selling 2,821 shares during the period. Ethic Inc.'s holdings in Agilent Technologies were worth $4,327,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. CKW Financial Group increased its position in Agilent Technologies by 114.9% in the 4th quarter. CKW Financial Group now owns 187 shares of the medical research company's stock worth $25,000 after purchasing an additional 100 shares during the last quarter. Global X Japan Co. Ltd. boosted its stake in shares of Agilent Technologies by 161.1% during the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company's stock worth $25,000 after acquiring an additional 116 shares in the last quarter. Redwood Park Advisors LLC bought a new stake in shares of Agilent Technologies during the 4th quarter worth about $27,000. Lee Danner & Bass Inc. bought a new stake in shares of Agilent Technologies during the 4th quarter worth about $29,000. Finally, Hanson & Doremus Investment Management boosted its stake in shares of Agilent Technologies by 66.5% during the 4th quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company's stock worth $35,000 after acquiring an additional 105 shares in the last quarter.

Insider Buying and Selling at Agilent Technologies

In related news, VP Rodney Gonsalves sold 1,908 shares of the firm's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the completion of the sale, the vice president now directly owns 21,786 shares of the company's stock, valued at $2,657,456.28. This trade represents a 8.05% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Daniel K. Podolsky sold 1,819 shares of the firm's stock in a transaction on Monday, March 31st. The shares were sold at an average price of $116.46, for a total value of $211,840.74. Following the sale, the director now directly owns 35,737 shares of the company's stock, valued at $4,161,931.02. This represents a 4.84% decrease in their ownership of the stock. The disclosure for this sale can be found here.

Analyst Ratings Changes

Several analysts have recently issued reports on the company. Jefferies Financial Group decreased their price target on Agilent Technologies from $135.00 to $116.00 and set a "hold" rating for the company in a research note on Monday, April 21st. Wells Fargo & Company decreased their price target on Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating for the company in a research note on Thursday, April 17th. Barclays decreased their price target on Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating for the company in a research note on Thursday, April 10th. Robert W. Baird decreased their price target on Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating for the company in a research note on Thursday, February 27th. Finally, TD Cowen increased their target price on Agilent Technologies to $135.00 and gave the company a "buy" rating in a research note on Thursday, April 10th. Seven research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $143.00.

Agilent Technologies Stock Performance

Agilent Technologies stock traded up $1.07 during trading hours on Friday, hitting $113.47. The stock had a trading volume of 723,243 shares, compared to its average volume of 1,897,402. The company has a 50-day moving average of $110.59 and a two-hundred day moving average of $128.32. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56. The company has a market cap of $32.35 billion, a PE ratio of 26.09, a price-to-earnings-growth ratio of 3.15 and a beta of 1.27. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $155.35.

Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating the consensus estimate of $1.27 by $0.04. The firm had revenue of $1.68 billion during the quarter, compared to analysts' expectations of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. On average, equities research analysts anticipate that Agilent Technologies, Inc. will post 5.54 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st were issued a $0.248 dividend. The ex-dividend date of this dividend was Tuesday, April 1st. This represents a $0.99 annualized dividend and a yield of 0.87%. Agilent Technologies's dividend payout ratio (DPR) is 22.76%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.